🇺🇸 FDA

Company profile · Sponsor

Eledon

Eledon Pharmaceuticals

ELDN · NYSE pharma IRVINE, CA, USA
Pipeline
9
Drugs
0
Patents
0

Quick answer

Eledon (ELDN) is a pharma company. headquartered in IRVINE, CA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ELDN
Exchange NYSE
Company type pharma
Headquarters IRVINE, CA, USA
SEC CIK 0001404281

Pipeline (9)

Search pipeline →

  1. AT-1501

    Eledon

    Type 1 Diabetes Mellitus

    phase 2 small molecule terminated

    1 trial

  2. AT-1501

    Eledon

    Amyotrophic Lateral Sclerosis

    phase 2 small molecule completed

    1 trial

  3. AT-1501

    Eledon

    IgA Nephropathy

    phase 2 small molecule terminated

    1 trial

  4. AT-1501

    Eledon

    Kidney Transplant Rejection

    phase 2 small molecule active

    2 trials

  5. AT-1501

    Eledon

    Prevention of Rejection in Kidney Transplant

    phase 2 small molecule active

    1 trial

  6. AT-1501 IV Infusion

    Eledon

    Brittle Type 1 Diabetes Mellitus

    phase 2 mab terminated

    1 trial

  7. Islet transplantation with Tegoprubart (AT-1501) immunosupression-based therapy

    Eledon

    Type 1 Diabetes Mellitus

    phase 2 small molecule active

    1 trial

  8. Prograf 5 mg hard capsules, Prograf 5 mg/ml concentrate for solution for infusion, AT-1501 190 mg Vial, Prograf 0.5 mg hard capsules, Prograf 1 mg hard capsules

    Eledon

    Prophylaxis of Renal Allograft Rejection

    phase 2 small molecule active

    1 trial

  9. Conditioning Regimen (Rituxan, Siplizumab, Cyclophosphamide, Tegoprubart)

    Eledon

    Kidney Failure

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Eledon?

Eledon (ELDN) is a pharma company. headquartered in IRVINE, CA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Eledon sponsor?

We track 9 ClinicalTrials.gov-linked programs for Eledon, including AT-1501 and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Eledon company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.